tirzepatide informed consent glp 1 drops Eli Lilly to seek approval of new GLP-1 weight-loss drug this year GLP-1 Weight Loss Consent Forms

, .

Adoption is accelerating as therapies such as tirzepatide (Mounjaro) gain early traction, while semaglutide brands including Wegovy and Rybelsus continue expanding their presence following recent pricing adjustments

Early research and patient feedback

Learn how semaglutide affects training, fatigue, muscle loss, and recoveryplus fueling, hydration, and periodization tactics to protect performance.

To help answer these and many others, I recently launched The GLP-1 Dietitian Hub, a growing community and newsletter dedicated to empowering dietitians with practical, up to date resources, relevant research, and a space to connect so we can navigate GLP-1 therapy with confidence

Read more about the differences in GLP-1s at the link below